Jie Tian

Risk factors associated with disease progression in a cohort of patients infected with the 2019 novel coronavirus.

Zhicheng Zhang, Yu-Long Zhou, Jie Tian, 2020, Annals of palliative medicine.

Efficacy and safety of Xiyanping injection in the treatment of COVID‐19: A multicenter, prospective, open‐label and randomized controlled trial

Xin-yi Zhang, Xiaoqun Ye, Yan Ding, 2021, Phytotherapy research : PTR.

Pathological Response and Tumor Immune Microenvironment Remodeling Upon Neoadjuvant ALK-TKI Treatment in ALK-Rearranged Non-Small Cell Lung Cancer

Rui-guang Zhang, Yong He, Li Li, 2023, Targeted Oncology.

Is a low dose of hepatitis B vaccine enough for a rapid vaccination scheme?

J. van Hattum, G. D. de Gast, G. Boland, 2003, World journal of gastroenterology.

TMEM44 as a Novel Prognostic Marker for Kidney Renal Clear Cell Carcinoma is Associated with Tumor Invasion, Migration and Immune Infiltration

Fei Liu, Jitao Chen, Liang Sun, 2023, Biochemical genetics.